Milestone Pharmaceuticals Inc. financial data

Symbol
MIST on Nasdaq
Location
1111 Boul. Dr. Frederik Philips, Ste 420, Montreal, Quebec, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 653 % -58.7%
Debt-to-equity 2.69K % +1214%
Return On Equity -2.37K % -1463%
Return On Assets -85.1 % -70.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.2M shares +59.7%
Common Stock, Shares, Outstanding 85.2M shares +59.7%
Entity Public Float 69.8M USD -27.2%
Common Stock, Value, Issued 312M USD +8.25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.5M USD +4.15%
General and Administrative Expense 16.2M USD +0.48%
Operating Income (Loss) -57.2M USD -31.4%
Net Income (Loss) Attributable to Parent -58M USD -35.6%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.7M USD +265%
Cash, Cash Equivalents, and Short-term Investments 82.6M USD +8.12%
Assets, Current 86.7M USD +7.01%
Property, Plant and Equipment, Net 136K USD -32.3%
Operating Lease, Right-of-Use Asset 944K USD -37.7%
Assets 87.8M USD +6.1%
Employee-related Liabilities, Current 2.41M USD +21.2%
Liabilities, Current 10.5M USD +100%
Operating Lease, Liability, Noncurrent 519K USD -48.2%
Liabilities 67.2M USD +14.6%
Retained Earnings (Accumulated Deficit) -413M USD -16.3%
Stockholders' Equity Attributable to Parent 20.5M USD -14.6%
Liabilities and Equity 87.8M USD +6.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14M USD -56.2%
Net Cash Provided by (Used in) Financing Activities 140K USD -99.6%
Net Cash Provided by (Used in) Investing Activities 33.6M USD
Common Stock, Shares, Issued 85.2M shares +59.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.8M USD
Deferred Tax Assets, Valuation Allowance 89.4M USD +11.4%
Deferred Tax Assets, Gross 89.4M USD +11.4%
Operating Lease, Liability 1.45M USD -27.9%
Payments to Acquire Property, Plant, and Equipment 6K USD
Lessee, Operating Lease, Liability, to be Paid 1.59M USD -30.1%
Property, Plant and Equipment, Gross 488K USD +4.27%
Operating Lease, Liability, Current 483K USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 530K USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 658K USD -2.23%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 149K USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three 406K USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 72.8M USD +9.18%
Lessee, Operating Lease, Liability, to be Paid, Year Four 406K USD -23.4%
Additional Paid in Capital 66.3M USD +73.9%
Depreciation, Depletion and Amortization 27K USD -3.57%
Share-based Payment Arrangement, Expense 5.38M USD -12.9%
Interest Expense 3.39M USD +2542%